Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab
Anais Brasileiros de Dermatologia · 2024
DOI: 10.1016/j.abd.2023.03.012 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anais Brasileiros de Dermatologia, 2024. Verfasst von Mayu Sato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Fukushima Medical University, Fukushima, Japan. Electronic address: s-mayu@fmu.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Drug Eruptions, Psoriasis. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan. Electronic address: s-mayu@fmu.ac.jp.
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Zitieren
APA
Sato, M., & Yamamoto, T. (2024). Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2023.03.012
Vancouver
Sato M, Yamamoto T. Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab. Anais Brasileiros de Dermatologia. 2024. doi:10.1016/j.abd.2023.03.012
BibTeX
@article{Sato2024,
author = {Sato, Mayu and Yamamoto, Toshiyuki},
title = {Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab},
journal = {Anais Brasileiros de Dermatologia},
year = {2024},
doi = {10.1016/j.abd.2023.03.012}
}
EUVIMED